Cellular senescence and protein degradation: Breaking down cancer

Cell Cycle

Volumn 13, Issue 12, 2014, Pages 1840-1858

  Deschênes Simard, Xavier ^a   Lessard, Frédéric ^a   Gaumont Leclerc, Marie France ^a   Bardeesy, Nabeel ^b   Ferbeyre, Gerardo ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

E3 ligases; ERK kinases; Ras oncogene; SASP; Ubiquitin

Indexed keywords

MESSENGER RNA; REACTIVE OXYGEN METABOLITE; UBIQUITIN PROTEIN LIGASE E3; PROTEOME; UBIQUITIN PROTEIN LIGASE;

AUTOPHAGY; BIOGENESIS; BREAST EPITHELIUM; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE ARREST; CELL VIABILITY; DNA DAMAGE; EUKARYOTIC CELL; GENE EXPRESSION; HUMAN; MACROAUTOPHAGY; MITOCHONDRION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN MODIFICATION; REVIEW; RIBOSOME; RNA TRANSLATION; SENESCENCE; CELL AGING; CELL CYCLE CHECKPOINT; METABOLISM; NEOPLASM; NUCLEOLUS; PATHOLOGY;

AUTOPHAGY; CELL AGING; CELL CYCLE CHECKPOINTS; CELL NUCLEOLUS; DNA DAMAGE; HUMANS; NEOPLASMS; PROTEOLYSIS; PROTEOME; RIBOSOMES; RNA, MESSENGER; UBIQUITIN-PROTEIN LIGASES;

EID: 84902436313     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.29335     Document Type: Review

References (269)

1. Salama R, Sadaie M, Hoare M, Narita M. Cellular senescence and its effector programs. Genes Dev 2014; 28:99-114; PMID:24449267; http://dx.doi.org/10.1101/gad.235184.113
2. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24:2463-79; PMID:21078816; http://dx.doi.org/10.1101/gad.1971610
3. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. Microarray analysis of replicative senescence. Curr Biol 1999; 9:939-45; PMID:10508581; http://dx.doi.org/10.1016/S0960-9822(99)80420-5
4. Zhang H, Pan KH, Cohen SN. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc Natl Acad Sci U S A 2003; 100:3251-6; PMID:12626749; http://dx.doi.org/10.1073/pnas.2627983100
5. Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, Premsrirut P, Luo W, Chicas A, Lee CS, et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25:2125-36; PMID:21979375; http://dx.doi.org/10.1101/gad. 17276711
6. Ohanna M, Giuliano S, Bonet C, Imbert V, Hofman V, Zangari J, Bille K, Robert C, Bressac-de Paillerets B, Hofman P, et al. Senescent cells develop a PARP-1 and nuclear factor-kappaB-associated secretome (PNAS). Genes Dev 2011; 25:1245-61; PMID:21646373; http://dx.doi.org/10.1101/gad.625811
7. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853-68; PMID:19053174; http://dx.doi.org/10.1371/ journal.pbio.0060301
8. Vernier M, Bourdeau V, Gaumont-Leclerc MF, Moiseeva O, Bégin V, Saad F, Mes-Masson AM, Ferbeyre G. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 2011; 25:41-50; PMID:21205865; http://dx.doi.org/10. 1101/gad.1975111
9. Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, Dickins RA, Narita M, Zhang M, Lowe SW. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 2010; 17:376-87; PMID:20385362; http://dx.doi.org/10.1016/j.ccr.2010.01.023
10. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277:831-4; PMID:9242615; http://dx.doi.org/10.1126/science.277.5327.831
11. Jackson JG, Pereira-Smith OM. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Res 2006; 66:8356-60; PMID:16951143; http://dx.doi.org/10.1158/0008-5472.CAN-06-1752
12. McConnell BB, Starborg M, Brookes S, Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 1998; 8:351-4; PMID:9512419; http://dx.doi.org/10.1016/S0960-9822(98)70137-X
13. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 2000; 14:2015-27; PMID:10950866
14. de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G, Lowe SW. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 2004; 13:523-35; PMID:14992722; http://dx.doi.org/10.1016/S1097- 2765(04)00062-0
15. Kortlever RM, Higgins PJ, Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 2006; 8:877-84; PMID:16862142; http://dx.doi.org/10. 1038/ncb1448
16. Aksoy O, Chicas A, Zeng T, Zhao Z, McCurrach M, Wang X, Lowe SW. The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence. Genes Dev 2012; 26:1546-57; PMID:22802529; http://dx.doi.org/10. 1101/gad.196238.112
17. Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22:4212-22; PMID:12912919; http://dx.doi.org/10.1093/ emboj/cdg417
18. Burns DM, Richter JD. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev 2008; 22:3449-60; PMID:19141477; http://dx.doi.org/10.1101/gad.1697808
19. Manfredi JJ. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev 2010; 24:1580-9; PMID:20679392; http://dx.doi.org/10.1101/gad.1941710
20. Petroulakis E, Parsyan A, Dowling RJ, LeBacquer O, Martineau Y, Bidinosti M, Larsson O, Alain T, Rong L, Mamane Y, et al. p53-dependent translational control of senescence and transformation via 4E-BPs. Cancer Cell 2009; 16:439-46; PMID:19878875; http://dx.doi.org/10.1016/j.ccr.2009.09.025
21. Scaglioni PP, Rabellino A, Yung TM, Bernardi R, Choi S, Konstantinidou G, Nardella C, Cheng K, Pandolfi PP. Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence. EMBO Mol Med 2012; 4:594-602; PMID:22359342; http://dx.doi.org/10.1002/emmm.201200233
22. Salomoni P, Dvorkina M, Michod D. Role of the promyelocytic leukaemia protein in cell death regulation. Cell Death Dis 2012; 3:e247; PMID:22237204; http://dx.doi.org/10.1038/cddis.2011.122
23. Louria-Hayon I, Alsheich-Bartok O, Levav-Cohen Y, Silberman I, Berger M, Grossman T, Matentzoglu K, Jiang YH, Muller S, Scheffner M, et al. E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ 2009; 16:1156-66; PMID:19325566; http://dx.doi.org/10.1038/cdd.2009.31
24. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, Tavaré S, Arakawa S, Shimizu S, Watt FM, et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009; 23:798-803; PMID:19279323; http://dx.doi.org/10.1101/gad.519709
25. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 147:728-41; PMID:22078875; http://dx.doi.org/10.1016/j.cell.2011.10.026
26. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM, Karantza V, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25:460-70; PMID:21317241; http://dx.doi.org/10.1101/gad.2016311
27. Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011; 25:717-29; PMID:21406549; http://dx.doi.org/10. 1101/gad.2016111
28. Maclean KH, Dorsey FC, Cleveland JL, Kastan MB. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 2008; 118:79-88; PMID:18097482; http://dx.doi.org/10.1172/JCI33700
29. Wei H, Wei S, Gan B, Peng X, Zou W, Guan JL. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 2011; 25:1510-27; PMID:21764854; http://dx.doi.org/10.1101/gad.2051011
30. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007; 7:961-7; PMID:17972889; http://dx.doi.org/10.1038/nrc2254
31. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-6; PMID:10604474; http://dx.doi.org/10.1038/45257
32. Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K, Mizushima N. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011; 25:795-800; PMID:21498569; http://dx.doi.org/10.1101/ gad.2016211
33. Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto M, et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 2011; 193:275-84; PMID:21482715; http://dx.doi.org/10.1083/jcb.201102031
34. Mariño G, Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N, López-Otín C. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 2007; 282:18573-83; PMID:17442669; http://dx.doi.org/10.1074/jbc.M701194200
35. Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y, Liang C, Jung JU, Cheng JQ, Mulé JJ, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007; 9:1142-51; PMID:17891140; http://dx.doi.org/10.1038/ncb1634
36. Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH, Jung JU. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006; 8:688-99; PMID:16799551; http://dx.doi.org/10.1038/ncb1426
37. Kim MS, Jeong EG, Ahn CH, Kim SS, Lee SH, Yoo NJ. Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol 2008; 39:1059-63; PMID:18495205; http://dx.doi.org/10. 1016/j.humpath.2007.11.013
38. Elgendy M, Sheridan C, Brumatti G, Martin SJ. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 2011; 42:23-35; PMID:21353614; http://dx.doi.org/10.1016/j.molcel.2011.02.009
39. Cuervo AM, Dice JF. Age-related decline in chaperone-mediated autophagy. J Biol Chem 2000; 275:31505-13; PMID:10806201; http://dx.doi.org/10.1074/jbc. M002102200
40. Wang Y, Wang XD, Lapi E, Sullivan A, Jia W, He YW, Ratnayaka I, Zhong S, Goldin RD, Goemans CG, et al. Autophagic activity dictates the cellular response to oncogenic RAS. Proc Natl Acad Sci U S A 2012; 109:13325-30; PMID:22847423; http://dx.doi.org/10.1073/pnas.1120193109
41. Gerland LM, Peyrol S, Lallemand C, Branche R, Magaud JP, Ffrench M. Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp Gerontol 2003; 38:887-95; PMID:12915210; http://dx.doi.org/10.1016/S0531-5565(03)00132-3
42. Capparelli C, Chiavarina B, Whitaker-Menezes D, Pestell TG, Pestell RG, Hulit J, Andò S, Howell A, Martinez-Outschoorn UE, Sotgia F, et al. CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle 2012; 11:3599-610; PMID:22935696; http://dx.doi.org/10.4161/cc.21884
43. Gamerdinger M, Hajieva P, Kaya AM, Wolfrum U, Hartl FU, Behl C. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J 2009; 28:889-901; PMID:19229298; http://dx.doi.org/10.1038/ emboj.2009.29
44. Singh K, Matsuyama S, Drazba JA, Almasan A. Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy 2012; 8:236-51; PMID:22240589; http://dx.doi.org/10.4161/auto.8.2.18600
45. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest 2010; 90:835-43; PMID:20212459; http://dx.doi.org/10.1038/ labinvest.2010.56
46. Mosieniak G, Adamowicz M, Alster O, Jaskowiak H, Szczepankiewicz AA, Wilczynski GM, Ciechomska IA, Sikora E. Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy. Mech Ageing Dev 2012; 133:444-55; PMID:22613224; http://dx.doi.org/10.1016/j.mad.2012.05. 004
47. Patschan S, Chen J, Polotskaia A, Mendelev N, Cheng J, Patschan D, Goligorsky MS. Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells. Am J Physiol Heart Circ Physiol 2008; 294:H1119-29; PMID:18203850; http://dx.doi.org/10.1152/ajpheart.00713.2007
48. Leidal AM, Cyr DP, Hill RJ, Lee PW, McCormick C. Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence. Cell Host Microbe 2012; 11:167-80; PMID:22341465; http://dx.doi.org/10.1016/j. chom.2012.01.005
49. Ivanov A, Pawlikowski J, Manoharan I, van Tuyn J, Nelson DM, Rai TS, Shah PP, Hewitt G, Korolchuk VI, Passos JF, et al. Lysosome-mediated processing of chromatin in senescence. J Cell Biol 2013; 202:129-43; PMID:23816621; http://dx.doi.org/10.1083/jcb.201212110
50. Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, Yoshida S, Hong S, Berry LS, Reichelt S, Ferreira M, et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011; 332:966-70; PMID:21512002; http://dx.doi.org/10.1126/science.1205407
51. Dörr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Däbritz JH, Lisec J, Lenze D, Gerhardt A, Schleicher K, et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 2013; 501:421-5; PMID:23945590; http://dx.doi.org/10.1038/nature12437
52. Mizushima N. Autophagy: process and function. Genes Dev 2007; 21:2861-73; PMID:18006683; http://dx.doi.org/10.1101/gad.1599207
53. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5:99-118; PMID:20078217; http://dx.doi.org/10.1146/ annurev-pathol-121808-102144
54. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133:1006-18; PMID:18555777; http://dx.doi.org/10.1016/j.cell.2008.03.038
55. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019-31; PMID:18555778; http://dx.doi.org/10.1016/j.cell.2008.03.039
56. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132:363-74; PMID:18267069; http://dx.doi.org/10.1016/ j.cell.2007.12.032
57. Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V, et al. Non-cell-autonomous tumor suppression by p53. Cell 2013; 153:449-60; PMID:23562644; http://dx.doi.org/10. 1016/j.cell.2013.03.020
58. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656-60; PMID:17251933; http://dx.doi.org/10.1038/nature05529
59. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, et al. Senescence surveillance of premalignant hepatocytes limits liver cancer development. Nature 2011; 479:547-51; PMID:22080947; http://dx.doi.org/10.1038/nature10599
60. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134:657-67; PMID:18724938; http://dx.doi.org/10.1016/j.cell.2008.06. 049
61. Deschênes-Simard X, Gaumont-Leclerc MF, Bourdeau V, Lessard F, Moiseeva O, Forest V, Igelmann S, Mallette FA, Saba-El-Leil MK, Meloche S, et al. Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes Dev 2013; 27:900-15; PMID:23599344; http://dx.doi.org/10.1101/gad.203984.112
62. de Jong A, Schuurman KG, Rodenko B, Ovaa H, Berkers CR. Fluorescence-based proteasome activity profiling. Methods Mol Biol 2012; 803:183-204; PMID:22065226; http://dx.doi.org/10.1007/978-1-61779-364-6-13
63. Deschênes-Simard X, Kottakis F, Meloche S, Ferbeyre G. ERKs in cancer: friends or foes? Cancer Res 2014; 74:412-9; PMID:24408923; http://dx.doi.org/10.1158/0008-5472.CAN-13-2381
64. Passos JF, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H, Wappler I, Birket MJ, Harold G, Schaeuble K, et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 2007; 5:e110; PMID:17472436; http://dx.doi.org/10.1371/journal.pbio.0050110
65. Moiseeva O, Bourdeau V, Roux A, Deschênes-Simard X, Ferbeyre G. Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol 2009; 29:4495-507; PMID:19528227; http://dx.doi.org/10.1128/MCB.01868-08
66. von Ballmoos C, Wiedenmann A, Dimroth P. Essentials for ATP synthesis by F1F0 ATP synthases. Annu Rev Biochem 2009; 78:649-72; PMID:19489730; http://dx.doi.org/10.1146/annurev.biochem.78.081307.104803
67. Zwerschke W, Mazurek S, Stöckl P, Hütter E, Eigenbrodt E, Jansen-Dürr P. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem J 2003; 376:403-11; PMID:12943534; http://dx.doi.org/10.1042/BJ20030816
68. Hutter E, Renner K, Pfister G, Stöckl P, Jansen-Dürr P, Gnaiger E. Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 2004; 380:919-28; PMID:15018610; http://dx.doi.org/10.1042/BJ20040095
69. Tammineni P, Anugula C, Mohammed F, Anjaneyulu M, Larner AC, Sepuri NB. The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J Biol Chem 2013; 288:4723-32; PMID:23271731; http://dx.doi.org/10.1074/jbc.M112.378984
70. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009; 323:793-7; PMID:19131594; http://dx.doi.org/10.1126/science.1164551
71. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009; 324:1713-6; PMID:19556508; http://dx.doi.org/10.1126/science.1171721
72. Elschami M, Scherr M, Philippens B, Gerardy-Schahn R. Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cells. Eur J Cell Biol 2013; 92:21-9; PMID:23102833; http://dx.doi.org/10.1016/ j.ejcb.2012.09.002
73. Zhang Q, Raje V, Yakovlev VA, Yacoub A, Szczepanek K, Meier J, Derecka M, Chen Q, Hu Y, Sisler J, et al. Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727. J Biol Chem 2013; 288:31280-8; PMID:24019511; http://dx.doi.org/10.1074/jbc.M113.505057
74. Faou P, Hoogenraad NJ. Tom34: a cytosolic cochaperone of the Hsp90/Hsp70 protein complex involved in mitochondrial protein import. Biochim Biophys Acta 2012; 1823:348-57; PMID:22178133; http://dx.doi.org/10.1016/j.bbamcr.2011.12.001
75. Rao S, Gerbeth C, Harbauer A, Mikropoulou D, Meisinger C, Schmidt O. Signaling at the gate: phosphorylation of the mitochondrial protein import machinery. Cell Cycle 2011; 10:2083-90; PMID:21606678; http://dx.doi.org/10. 4161/cc.10.13.16054
76. Gabai VL, Yaglom JA, Waldman T, Sherman MY. Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol Cell Biol 2009; 29:559-69; PMID:19001088; http://dx.doi.org/10.1128/MCB.01041-08
77. Morimoto RI. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 2008; 22:1427-38; PMID:18519635; http://dx.doi.org/10.1101/gad.1657108
78. Passos JF, Saretzki G, von Zglinicki T. DNA damage in telomeres and mitochondria during cellular senescence: is there a connection? Nucleic Acids Res 2007; 35:7505-13; PMID:17986462; http://dx.doi.org/10.1093/nar/gkm893
79. Kaplon J, Zheng L, Meissl K, Chaneton B, Selivanov VA, Mackay G, van der Burg SH, Verdegaal EM, Cascante M, Shlomi T, et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013; 498:109-12; PMID:23685455; http://dx.doi.org/10.1038/nature12154
80. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997; 272:20313-6; PMID:9252331; http://dx.doi.org/10.1074/jbc.272.33.20313
81. Davies MJ. The oxidative environment and protein damage. Biochim Biophys Acta 2005; 1703:93-109; PMID:15680218; http://dx.doi.org/10.1016/j.bbapap.2004. 08.007
82. Dai C, Dai S, Cao J. Proteotoxic stress of cancer: implication of the heat-shock response in oncogenesis. J Cell Physiol 2012; 227:2982-7; PMID:22105155; http://dx.doi.org/10.1002/jcp.24017
83. Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev 2009; 61:310-8; PMID:19248813; http://dx.doi.org/10.1016/j.addr.2009.02.003
84. Sherman M. Major heat shock protein Hsp72 controls oncogene-induced senescence. Ann N Y Acad Sci 2010; 1197:152-7; PMID:20536844; http://dx.doi.org/10.1111/j.1749-6632.2010.05196.x
85. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, Jäättelä M. Members of the heatshock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 2005; 19:570-82; PMID:15741319; http://dx.doi.org/10.1101/gad.305405
86. Yaglom JA, Gabai VL, Sherman MY. High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res 2007; 67:2373-81; PMID:17332370; http://dx.doi.org/10.1158/0008-5472.CAN-06-3796
87. Kim G, Meriin AB, Gabai VL, Christians E, Benjamin I, Wilson A, Wolozin B, Sherman MY. The heat shock transcription factor Hsf1 is downregulated in DNA damage-associated senescence, contributing to the maintenance of senescence phenotype. Aging Cell 2012; 11:617-27; PMID:22510478; http://dx.doi.org/10.1111/ j.1474-9726.2012.00827.x
88. Bonelli MA, Alfieri RR, Petronini PG, Brigotti M, Campanini C, Borghetti AF. Attenuated expression of 70-kDa heat shock protein in WI-38 human fibroblasts during aging in vitro. Exp Cell Res 1999; 252:20-32; PMID:10502396; http://dx.doi.org/10.1006/excr.1999.4614
89. O'Callaghan-Sunol C, Gabai VL, Sherman MY. Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 2007; 67:11779-88; PMID:18089808; http://dx.doi.org/10.1158/0008-5472.CAN-07-2441
90. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007; 130:1005-18; PMID:17889646; http://dx.doi.org/10.1016/j.cell.2007.07.020
91. De Raedt T, Walton Z, Yecies JL, Li D, Chen Y, Malone CF, Maertens O, Jeong SM, Bronson RT, Lebleu V, et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell 2011; 20:400-13; PMID:21907929; http://dx.doi.org/10.1016/j.ccr.2011.08.014
92. Murphy ME. The HSP70 family and cancer. Carcinogenesis 2013; 34:1181-8; PMID:23563090; http://dx.doi.org/10.1093/carcin/bgt111
93. Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005; 5:761-72; PMID:16175177; http://dx.doi.org/10.1038/nrc1716
94. Lamark T, Johansen T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int J Cell Biol 2012; 2012:736905; PMID:22518139; http://dx.doi.org/10.1155/2012/736905
95. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 2003; 426:895-9; PMID:14685250; http://dx.doi.org/10. 1038/nature02263
96. Marques C, Guo W, Pereira P, Taylor A, Patterson C, Evans PC, Shang F. The triage of damaged proteins: degradation by the ubiquitin-proteasome pathway or repair by molecular chaperones. FASEB J 2006; 20:741-3; PMID:16469848
97. Sisoula C, Gonos ES. CHIP E3 ligase regulates mammalian senescence by modulating the levels of oxidized proteins. Mech Ageing Dev 2011; 132:269-72; PMID:21510971; http://dx.doi.org/10.1016/j.mad.2011.04.003
98. Aiken CT, Kaake RM, Wang X, Huang L. Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteomics 2011; 10:006924; PMID:21543789; http://dx.doi.org/10.1074/mcp.M110.006924
99. Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003; 13:1549-56; PMID:12956959; http://dx.doi.org/10.1016/ S0960-9822(03)00542-6
100. Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, Kaplunov JM, Bucci G, Dobreva M, Matti V, Beausejour CM, et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 2012; 14:355-65; PMID:22426077; http://dx.doi.org/10.1038/ncb2466
101. Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, Coppé JP, Campeau E, Beauséjour CM, Kim SH, et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 2011; 124:68-81; PMID:21118958; http://dx.doi.org/10.1242/jcs.071340
102. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008; 8:512-22; PMID:18574463; http://dx.doi.org/10.1038/nrc2440
103. Mallette FA, Ferbeyre G. The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 2007; 6:1831-6; PMID:17671427; http://dx.doi.org/10.4161/cc.6.15.4516
104. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194-8; PMID:14608368; http://dx.doi.org/10.1038/nature02118
105. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 2004; 14:501-13; PMID:15149599; http://dx.doi.org/10.1016/S1097-2765(04)00256-4
106. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633-7; PMID:17136093; http://dx.doi.org/10.1038/ nature05268
107. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre' M, Nuciforo PG, Bensimon A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10.1038/nature05327
108. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 2007; 21:43-8; PMID:17210786; http://dx.doi.org/10.1101/gad.1487307
109. Merolla F, Pentimalli F, Pacelli R, Vecchio G, Fusco A, Grieco M, Celetti A. Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. Oncogene 2007; 26:6167-75; PMID:17420723; http://dx.doi.org/10.1038/sj.onc. 1210446
110. Zhao J, Tang J, Men W, Ren K. FBXW7-mediated degradation of CCDC6 is impaired by ATM during DNA damage response in lung cancer cells. FEBS Lett 2012; 586:4257-63; PMID:23108047; http://dx.doi.org/10.1016/j.febslet.2012.10.029
111. Moiseeva O, Bourdeau V, Roux A, Deschênes-Simard X, Ferbeyre G. Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol 2009; 29:4495-507; PMID:19528227; http://dx.doi.org/10.1128/MCB.01868-08
112. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard BH, Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 1999; 274:7936-40; PMID:10075689; http://dx.doi.org/10.1074/jbc.274.12.7936
113. Lu T, Finkel T. Free radicals and senescence. Exp Cell Res 2008; 314:1918-22; PMID:18282568; http://dx.doi.org/10.1016/j.yexcr.2008.01.011
114. Cui H, Kong Y, Zhang H. Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduct 2012; 2012:646354; PMID:21977319; http://dx.doi.org/ 10.1155/2012/646354
115. Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, Epstein CJ, Huang TT. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005; 24:367-80; PMID:15531919; http://dx.doi.org/10.1038/sj.onc.1208207
116. Blander G, de Oliveira RM, Conboy CM, Haigis M, Guarente L. Superoxide dismutase 1 knock-down induces senescence in human fibroblasts. J Biol Chem 2003; 278:38966-9; PMID:12871978; http://dx.doi.org/10.1074/jbc.M307146200
117. Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 2002; 3:430-40; PMID:12042765; http://dx.doi.org/10.1038/ nrm831
118. Bermejo R, Doksani Y, Capra T, Katou YM, Tanaka H, Shirahige K, Foiani M. Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation. Genes Dev 2007; 21:1921-36; PMID:17671091; http://dx.doi.org/10.1101/gad.432107
119. Cuvier O, Stanojcic S, Lemaitre JM, Mechali M. A topoisomerase II-dependent mechanism for resetting replicons at the S-M-phase transition. Genes Dev 2008; 22:860-5; PMID:18381889; http://dx.doi.org/10.1101/gad.445108
120. Fachinetti D, Bermejo R, Cocito A, Minardi S, Katou Y, Kanoh Y, Shirahige K, Azvolinsky A, Zakian VA, Foiani M. Replication termination at eukaryotic chromosomes is mediated by Top2 and occurs at genomic loci containing pausing elements. Mol Cell 2010; 39:595-605; PMID:20797631; http://dx.doi.org/10.1016/j. molcel.2010.07.024
121. Baxter J, Diffley JF. Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast. Mol Cell 2008; 30:790-802; PMID:18570880; http://dx.doi.org/10.1016/j.molcel.2008.04.019
122. Holm C, Stearns T, Botstein D. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol Cell Biol 1989; 9:159-68; PMID:2538717
123. Bermejo R, Capra T, Gonzalez-Huici V, Fachinetti D, Cocito A, Natoli G, Katou Y, Mori H, Kurokawa K, Shirahige K, et al. Genome-organizing factors Top2 and Hmo1 prevent chromosome fragility at sites of S phase transcription. Cell 2009; 138:870-84; PMID:19737516; http://dx.doi.org/10.1016/j.cell.2009.06.022
124. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10; PMID:16166375; http://dx.doi.org/ 10.1101/gad.1346005
125. Li B, Oestreich S, de Lange T. Identification of human Rap1: implications for telomere evolution. Cell 2000; 101:471-83; PMID:10850490; http://dx.doi.org/10.1016/S0092-8674(00)80858-2
126. Crabbe L, Cesare AJ, Kasuboski JM, Fitzpatrick JA, Karlseder J. Human telomeres are tethered to the nuclear envelope during postmitotic nuclear assembly. Cell Rep 2012; 2:1521-9; PMID:23260663; http://dx.doi.org/10.1016/j. celrep.2012.11.019
127. Bae NS, Baumann P. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol Cell 2007; 26:323-34; PMID:17499040; http://dx.doi.org/10.1016/j.molcel.2007.03.023
128. Sarthy J, Bae NS, Scrafford J, Baumann P. Human RAP1 inhibits non-homologous end joining at telomeres. EMBO J 2009; 28:3390-9; PMID:19763083; http://dx.doi.org/10.1038/emboj.2009.275
129. Hewitt G, Jurk D, Marques FD, Correia-Melo C, Hardy T, Gackowska A, Anderson R, Taschuk M, Mann J, Passos JF. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 2012; 3:708; PMID:22426229; http://dx.doi.org/10.1038/ncomms1708
130. Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, Boccardi V, Fumagalli M, Di Micco R, Mirani N, Gurung RL, et al. Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J 2012; 31:2839-51; PMID:22569128; http://dx.doi.org/10.1038/emboj.2012.132
131. Lee OH, Kim H, He Q, Baek HJ, Yang D, Chen LY, Liang J, Chae HK, Safari A, Liu D, et al. Genomewide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells. Mol Cell Proteomics 2011; 10:001628; PMID:21044950; http://dx.doi.org/10.1074/mcp.M110.001628
132. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honoré N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, et al. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 2001; 193:1361-71; PMID:11413191; http://dx.doi.org/10.1084/jem.193.12.1361
133. Buschbeck M, Uribesalgo I, Ledl A, Gutierrez A, Minucci S, Muller S, Di Croce L. PML4 induces differentiation by Myc destabilization. Oncogene 2007; 26:3415-22; PMID:17146439; http://dx.doi.org/10.1038/sj.onc.1210128
134. Vennemann A, Hofmann TG. SUMO regulates proteasome-dependent degradation of FLASH/Casp8AP2. Cell Cycle 2013; 12:1914-21; PMID:23673342; http://dx.doi.org/10.4161/cc.24943
135. Sharma P, Murillas R, Zhang H, Kuehn MR. N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies. J Cell Sci 2010; 123:1227-34; PMID:20233849; http://dx.doi.org/10.1242/jcs.060160
136. Moss T. At the crossroads of growth control; making ribosomal RNA. Curr Opin Genet Dev 2004; 14:210-7; PMID:15196469; http://dx.doi.org/10.1016/j.gde. 2004.02.005
137. Yang Y, Isaac C, Wang C, Dragon F, Pogacic V, Meier UT. Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140. Mol Biol Cell 2000; 11:567-77; PMID:10679015; http://dx.doi.org/10.1091/mbc.11.2.567
138. Tsai YT, Lin CI, Chen HK, Lee KM, Hsu CY, Yang SJ, Yeh NH. Chromatin tethering effects of hNopp140 are involved in the spatial organization of nucleolus and the rRNA gene transcription. J Biomed Sci 2008; 15:471-86; PMID:18253863; http://dx.doi.org/10.1007/s11373-007-9226-7
139. Lechertier T, Grob A, Hernandez-Verdun D, Roussel P. Fibrillarin and Nop56 interact before being co-assembled in box C/D snoRNPs. Exp Cell Res 2009; 315:928-42; PMID:19331828; http://dx.doi.org/10.1016/j.yexcr.2009.01.016
140. Srivastava L, Lapik YR, Wang M, Pestov DG. Mammalian DEAD box protein Ddx51 acts in 3′ end maturation of 28S rRNA by promoting the release of U8 snoRNA. Mol Cell Biol 2010; 30:2947-56; PMID:20404093; http://dx.doi.org/10. 1128/MCB.00226-10
141. Utama B, Kennedy D, Ru K, Mattick JS. Isolation and characterization of a new nucleolar protein, Nrap, that is conserved from yeast to humans. Genes Cells 2002; 7:115-32; PMID:11895476; http://dx.doi.org/10.1046/j.1356-9597.2001. 00507.x
142. Wu J, Zhang Y, Wang Y, Kong R, Hu L, Schuele R, Du X, Ke Y. Transcriptional repressor NIR functions in the ribosome RNA processing of both 40S and 60S subunits. PLoS One 2012; 7:e31692; PMID:22363708; http://dx.doi.org/10.1371/journal.pone.0031692
143. Abdelmohsen K, Gorospe M. RNA-binding protein nucleolin in disease. RNA Biol 2012; 9:799-808; PMID:22617883; http://dx.doi.org/10.4161/rna.19718
144. Artero-Castro A, Kondoh H, Fernández-Marcos PJ, Serrano M, Ramón y Cajal S, Lleonart ME. Rplp1 bypasses replicative senescence and contributes to transformation. Exp Cell Res 2009; 315:1372-83; PMID:19233166; http://dx.doi.org/10.1016/j.yexcr.2009.02.007
145. Ma L, Chang N, Guo S, Li Q, Zhang Z, Wang W, Tong T. CSIG inhibits PTEN translation in replicative senescence. Mol Cell Biol 2008; 28:6290-301; PMID:18678645; http://dx.doi.org/10.1128/MCB.00142-08
146. Meng L, Yasumoto H, Tsai RY. Multiple controls regulate nucleostemin partitioning between nucleolus and nucleoplasm. J Cell Sci 2006; 119:5124-36; PMID:17158916; http://dx.doi.org/10.1242/jcs.03292
147. Romanova L, Grand A, Zhang L, Rayner S, Katoku-Kikyo N, Kellner S, Kikyo N. Critical role of nucleostemin in pre-rRNA processing. J Biol Chem 2009; 284:4968-77; PMID:19106111; http://dx.doi.org/10.1074/jbc.M804594200
148. Mialon A, Thastrup J, Kallunki T, Mannermaa L, Westermarck J, Holmström TH. Identification of nucleolar effects in JNK-deficient cells. FEBS Lett 2008; 582:3145-51; PMID:18703060; http://dx.doi.org/10.1016/j.febslet. 2008.08.004
149. Tafforeau L, Zorbas C, Langhendries JL, Mullineux ST, Stamatopoulou V, Mullier R, Wacheul L, Lafontaine DL. The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors. Mol Cell 2013; 51:539-51; PMID:23973377; http://dx.doi.org/10.1016/j.molcel.2013.08. 011
150. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001; 2:731-7; PMID:11584300; http://dx.doi.org/10.1038/35096061
151. Ferbeyre G, de Stanchina E, Lin AW, Querido E, McCurrach ME, Hannon GJ, Lowe SW. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol 2002; 22:3497-508; PMID:11971980; http://dx.doi.org/10.1128/MCB.22.10. 3497-3508.2002
152. Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 2013; 13:83-96; PMID:23303139; http://dx.doi.org/10. 1038/nrc3430
153. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 2003; 12:1151-64; PMID:14636574; http://dx.doi.org/10.1016/S1097-2765(03)00431-3
154. Tago K, Chiocca S, Sherr CJ. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc Natl Acad Sci U S A 2005; 102:7689-94; PMID:15897463; http://dx.doi.org/10.1073/pnas.0502978102
155. Lessard F, Morin F, Ivanchuk S, Langlois F, Stefanovsky V, Rutka J, Moss T. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I. Mol Cell 2010; 38:539-50; PMID:20513429; http://dx.doi.org/10.1016/j.molcel.2010.03.015
156. Drygin D, Lin A, Bliesath J, Ho CB, O'Brien SE, Proffitt C, Omori M, Haddach M, Schwaebe MK, Siddiqui-Jain A, et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res 2011; 71:1418-30; PMID:21159662; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-1728
157. Quin JE, Devlin JR, Cameron D, Hannan KM, Pearson RB, Hannan RD. Targeting the nucleolus for cancer intervention. Biochim Biophys Acta 2014; 1842:802-16; PMID:24389329; http://dx.doi.org/10.1016/j.bbadis.2013.12.009
158. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149:274-93; PMID:22500797; http://dx.doi.org/10.1016/j.cell.2012.03. 017
159. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606
160. Leontieva OV, Natarajan V, Demidenko ZN, Burdelya LG, Gudkov AV, Blagosklonny MV. Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci U S A 2012; 109:13314-8; PMID:22847439; http://dx.doi.org/10.1073/pnas.1205690109
161. Leontieva OV, Demidenko ZN, Blagosklonny MV. MEK drives cyclin D1 hyperelevation during geroconversion. Cell Death Differ 2013; 20:1241-9; PMID:23852369; http://dx.doi.org/10.1038/cdd.2013.86
162. Blagosklonny MV. Hypoxia, MTOR and autophagy: converging on senescence or quiescence. Autophagy 2013; 9:260-2; PMID:23192222; http://dx.doi.org/10.4161/ auto.22783
163. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY) 2012; 4:159-65; PMID:22394614
164. Kolesnichenko M, Hong L, Liao R, Vogt PK, Sun P. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 2012; 11:2391-401; PMID:22627671; http://dx.doi.org/10.4161/cc.20683
165. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9:153-66; PMID:19238148; http://dx.doi.org/10. 1038/nrc2602
166. Xie Q, Chen J, Feng H, Peng S, Adams U, Bai Y, Huang L, Li J, Huang J, Meng S, et al. YAP/TEAD-mediated transcription controls cellular senescence. Cancer Res 2013; 73:3615-24; PMID:23576552; http://dx.doi.org/10.1158/0008-5472. CAN-12-3793
167. Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X, et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell 2008; 32:803-14; PMID:19111660; http://dx.doi.org/10.1016/j.molcel.2008.11.019
168. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009; 16:425-38; PMID:19878874; http://dx.doi.org/10.1016/ j.ccr.2009.09.026
169. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 2010; 24:72-85; PMID:20048001; http://dx.doi.org/10.1101/gad.1843810
170. Gulshan K, Thommandru B, Moye-Rowley WS. Proteolytic degradation of the Yap1 transcription factor is regulated by subcellular localization and the E3 ubiquitin ligase Not4. J Biol Chem 2012; 287:26796-805; PMID:22707721; http://dx.doi.org/10.1074/jbc.M112.384719
171. Fernández-Cid A, Riera A, Tognetti S, Herrera MC, Samel S, Evrin C, Winkler C, Gardenal E, Uhle S, Speck C. An ORC/Cdc6/MCM2-7 complex is formed in a multistep reaction to serve as a platform for MCM double-hexamer assembly. Mol Cell 2013; 50:577-88; PMID:23603117; http://dx.doi.org/10.1016/j.molcel. 2013.03.026
172. Labib K, Tercero JA, Diffley JF. Uninterrupted MCM2-7 function required for DNA replication fork progression. Science 2000; 288:1643-7; PMID:10834843; http://dx.doi.org/10.1126/science.288.5471.1643
173. Shen Z, Sathyan KM, Geng Y, Zheng R, Chakraborty A, Freeman B, Wang F, Prasanth KV, Prasanth SG. A WD-repeat protein stabilizes ORC binding to chromatin. Mol Cell 2010; 40:99-111; PMID:20932478; http://dx.doi.org/10.1016/j. molcel.2010.09.021
174. Shen Z, Prasanth SG. Orc2 protects ORCA from ubiquitin-mediated degradation. Cell Cycle 2012; 11:3578-89; PMID:22935713; http://dx.doi.org/10. 4161/cc.21870
175. Kotake Y, Zeng Y, Xiong Y. DDB1-CUL4 and MLL1 mediate oncogene-induced p16INK4a activation. Cancer Res 2009; 69:1809-14; PMID:19208841; http://dx.doi.org/10.1158/0008-5472.CAN-08-2739
176. Choi SH, Wright JB, Gerber SA, Cole MD. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev 2010; 24:1236-41; PMID:20551172; http://dx.doi.org/10.1101/gad.1920310
177. Dang CV. MYC on the path to cancer. Cell 2012; 149:22-35; PMID:22464321; http://dx.doi.org/10.1016/j.cell.2012.03.003
178. Wu CH, van Riggelen J, Yetil A, Fan AC, Bachireddy P, Felsher DW. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci U S A 2007; 104:13028-33; PMID:17664422; http://dx.doi.org/10.1073/pnas.0701953104
179. Mallette FA, Gaumont-Leclerc MF, Huot G, Ferbeyre G. Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence. J Biol Chem 2007; 282:34938-44; PMID:17913706; http://dx.doi.org/10.1074/jbc.M707074200
180. Hydbring P, Bahram F, Su Y, Tronnersjö S, Högstrand K, von der Lehr N, Sharifi HR, Lilischkis R, Hein N, Wu S, et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci U S A 2010; 107:58-63; PMID:19966300; http://dx.doi.org/10.1073/ pnas.0900121106
181. Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak JA, Berman AE, Giordano TJ, Prochownik EV, Soengas MS, et al. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 2008; 27:6623-34; PMID:18679422; http://dx.doi.org/10. 1038/onc.2008.258
182. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116-25; PMID:15103331; http://dx.doi.org/10.1038/sj.emboj.7600217
183. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A 2004; 101:9085-90; PMID:15150404; http://dx.doi.org/10.1073/pnas.0402770101
184. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003; 11:1189-200; PMID:12769844; http://dx.doi.org/10.1016/S1097-2765(03)00193-X
185. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. Skp2 regulates Myc protein stability and activity. Mol Cell 2003; 11:1177-88; PMID:12769843; http://dx.doi.org/10.1016/S1097-2765(03)00173-4
186. Paul I, Ahmed SF, Bhowmik A, Deb S, Ghosh MK. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene 2013; 32:1284-95; PMID:22543587; http://dx.doi.org/10.1038/onc.2012.144
187. Inoue S, Hao Z, Elia AJ, Cescon D, Zhou L, Silvester J, Snow B, Harris IS, Sasaki M, Li WY, et al. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15. Genes Dev 2013; 27:1101-14; PMID:23699408; http://dx.doi.org/10.1101/gad.214577. 113
188. Kimura Y, Nagao A, Fujioka Y, Satou A, Taira T, Iguchi-Ariga SM, Ariga H. MM-1 facilitates degradation of c-Myc by recruiting proteasome and a novel ubiquitin E3 ligase. Int J Oncol 2007; 31:829-36; PMID:17786314
189. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3:859-68; PMID:14668816; http://dx.doi.org/10.1038/nrc1209
190. Wisdom R, Johnson RS, Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 1999; 18:188-97; PMID:9878062; http://dx.doi.org/10.1093/emboj/18.1.188
191. Schreiber M, Kolbus A, Piu F, Szabowski A, Möhle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999; 13:607-19; PMID:10072388; http://dx.doi.org/10. 1101/gad.13.5.607
192. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011; 11:792-804; PMID:21979307; http://dx.doi.org/10.1038/nrc3139
193. Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher FJ 3rd, Chen J. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J 2005; 24:3279-90; PMID:16107876; http://dx.doi.org/10.1038/sj.emboj. 7600791
194. Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 2010; 39:963-74; PMID:20864041; http://dx.doi.org/10.1016/j.molcel.2010.08.029
195. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-12; PMID:18431400; http://dx.doi.org/10.1038/nrm2395
196. Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, Ann DK. Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. J Biol Chem 2007; 282:36177-89; PMID:17942393; http://dx.doi.org/10.1074/jbc.M706912200
197. Lee YK, Thomas SN, Yang AJ, Ann DK. Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J Biol Chem 2007; 282:1595-606; PMID:17079232; http://dx.doi.org/10.1074/jbc.M606306200
198. Kepkay R, Attwood KM, Ziv Y, Shiloh Y, Dellaire G. KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin. Cell Cycle 2011; 10:308-22; PMID:21228624; http://dx.doi.org/10.4161/ cc.10.2.14551
199. Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 2000; 26:291-9; PMID:11062467; http://dx.doi.org/10.1038/81583
200. Vance KW, Carreira S, Brosch G, Goding CR. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res 2005; 65:2260-8; PMID:15781639; http://dx.doi.org/10.1158/0008-5472.CAN-04-3045
201. Lüdtke TH, Farin HF, Rudat C, Schuster-Gossler K, Petry M, Barnett P, Christoffels VM, Kispert A. Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b. PLoS Genet 2013; 9:e1003189; PMID:23341776; http://dx.doi.org/10.1371/journal.pgen.1003189
202. Martin N, Benhamed M, Nacerddine K, Demarque MD, van Lohuizen M, Dejean A, Bischof O. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence. EMBO J 2012; 31:95-109; PMID:22002537; http://dx.doi.org/10.1038/emboj.2011.370
203. Lu ZH, Books JT, Ley TJ. YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. Mol Cell Biol 2005; 25:4625-37; PMID:15899865; http://dx.doi.org/10. 1128/MCB.25.11.4625-4637.2005
204. Dolfini D, Mantovani R. Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y? Cell Death Differ 2013; 20:676-85; PMID:23449390; http://dx.doi.org/10. 1038/cdd.2013.13
205. Lasham A, Samuel W, Cao H, Patel R, Mehta R, Stern JL, Reid G, Woolley AG, Miller LD, Black MA, et al. YB-1, the E2F pathway, and regulation of tumor cell growth. J Natl Cancer Inst 2012; 104:133-46; PMID:22205655; http://dx.doi.org/10.1093/jnci/djr512
206. Lasham A, Moloney S, Hale T, Homer C, Zhang YF, Murison JG, Braithwaite AW, Watson J. The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor. J Biol Chem 2003; 278:35516-23; PMID:12835324; http://dx.doi.org/10.1074/jbc.M303920200
207. Lyabin DN, Eliseeva IA, Ovchinnikov LP. YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA 2014; 5:95-110; PMID:24217978; http://dx.doi.org/10.1002/wrna.1200
208. Dutertre M, Sanchez G, De Cian MC, Barbier J, Dardenne E, Gratadou L, Dujardin G, Le Jossic-Corcos C, Corcos L, Auboeuf D. Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol 2010; 17:1358-66; PMID:20972445; http://dx.doi.org/10.1038/nsmb.1912
209. Chibi M, Meyer M, Skepu A, G Rees DJ, Moolman-Smook JC, Pugh DJ. RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1. J Mol Biol 2008; 384:908-16; PMID:18851979; http://dx.doi.org/10.1016/j.jmb.2008.09.060
210. Blencowe BJ, Issner R, Nickerson JA, Sharp PA. A coactivator of pre-mRNA splicing. Genes Dev 1998; 12:996-1009; PMID:9531537; http://dx.doi.org/10.1101/ gad.12.7.996
211. Eldridge AG, Li Y, Sharp PA, Blencowe BJ. The SRm160/300 splicing coactivator is required for exon-enhancer function. Proc Natl Acad Sci U S A 1999; 96:6125-30; PMID:10339552; http://dx.doi.org/10.1073/pnas.96.11.6125
212. Szymczyna BR, Bowman J, McCracken S, Pineda-Lucena A, Lu Y, Cox B, Lambermon M, Graveley BR, Arrowsmith CH, Blencowe BJ. Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-mRNA processing. Genes Dev 2003; 17:461-75; PMID:12600940; http://dx.doi.org/10.1101/ gad.1060403
213. Blencowe BJ, Baurén G, Eldridge AG, Issner R, Nickerson JA, Rosonina E, Sharp PA. The SRm160/300 splicing coactivator subunits. RNA 2000; 6:111-20; PMID:10668804; http://dx.doi.org/10.1017/S1355838200991982
214. Wójcik C, DeMartino GN. Intracellular localization of proteasomes. Int J Biochem Cell Biol 2003; 35:579-89; PMID:12672451; http://dx.doi.org/10. 1016/S1357-2725(02)00380-1
215. Wigley WC, Fabunmi RP, Lee MG, Marino CR, Muallem S, DeMartino GN, Thomas PJ. Dynamic association of proteasomal machinery with the centrosome. J Cell Biol 1999; 145:481-90; PMID:10225950; http://dx.doi.org/10.1083/jcb.145.3.481
216. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN. Activity and regulation of the centrosome-associated proteasome. J Biol Chem 2000; 275:409-13; PMID:10617632; http://dx.doi.org/10.1074/jbc.275.1.409
217. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN. Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J Cell Sci 2001; 114:29-36; PMID:11112687
218. Mattsson K, Pokrovskaja K, Kiss C, Klein G, Szekely L. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc Natl Acad Sci U S A 2001; 98:1012-7; PMID:11158586; http://dx.doi.org/10.1073/pnas.98.3.1012
219. von Mikecz A. The nuclear ubiquitin-proteasome system. J Cell Sci 2006; 119:1977-84; PMID:16687735; http://dx.doi.org/10.1242/jcs.03008
220. Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 2007; 8:1006-16; PMID:17928811; http://dx.doi.org/10.1038/nrm2277
221. Chen M, Rockel T, Steinweger G, Hemmerich P, Risch J, von Mikecz A. Subcellular recruitment of fibrillarin to nucleoplasmic proteasomes: implications for processing of a nucleolar autoantigen. Mol Biol Cell 2002; 13:3576-87; PMID:12388758; http://dx.doi.org/10.1091/mbc.02-05-0083
222. Rockel TD, Stuhlmann D, von Mikecz A. Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J Cell Sci 2005; 118:5231-42; PMID:16249232; http://dx.doi.org/10.1242/jcs.02642
223. Arabi A, Rustum C, Hallberg E, Wright AP. Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J Cell Sci 2003; 116:1707-17; PMID:12665552; http://dx.doi.org/10.1242/jcs.00370
224. Lamond AI, Spector DL. Nuclear speckles: a model for nuclear organelles. Nat Rev Mol Cell Biol 2003; 4:605-12; PMID:12923522; http://dx.doi.org/10.1038/ nrm1172
225. Baldin V, Militello M, Thomas Y, Doucet C, Fic W, Boireau S, Jariel-Encontre I, Piechaczyk M, Bertrand E, Tazi J, et al. A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking. Mol Biol Cell 2008; 19:1706-16; PMID:18256291; http://dx.doi.org/10.1091/mbc. E07-07-0637
226. Lafarga M, Berciano MT, Pena E, Mayo I, Castaño JG, Bohmann D, Rodrigues JP, Tavanez JP, Carmo-Fonseca M. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. Mol Biol Cell 2002; 13:2771-82; PMID:12181345; http://dx.doi.org/10. 1091/mbc.E02-03-0122
227. Smith KP, Byron M, O'Connell BC, Tam R, Schorl C, Guney I, Hall LL, Agrawal P, Sedivy JM, Lawrence JB. c-Myc localization within the nucleus: evidence for association with the PML nuclear body. J Cell Biochem 2004; 93:1282-96; PMID:15503302; http://dx.doi.org/10.1002/jcb.20273
228. Herrmann A, Sommer U, Pranada AL, Giese B, Küster A, Haan S, Becker W, Heinrich PC, Müller-Newen G. STAT3 is enriched in nuclear bodies. J Cell Sci 2004; 117:339-49; PMID:14657276; http://dx.doi.org/10.1242/jcs.00833
229. Kawasaki A, Matsumura I, Kataoka Y, Takigawa E, Nakajima K, Kanakura Y. Opposing effects of PML and PML/RAR alpha on STAT3 activity. Blood 2003; 101:3668-73; PMID:12506013; http://dx.doi.org/10.1182/blood-2002-08-2474
230. St-Germain JR, Chen J, Li Q. Involvement of PML nuclear bodies in CBP degradation through the ubiquitin-proteasome pathway. Epigenetics 2008; 3:342- 9; PMID:19011377; http://dx.doi.org/10.4161/epi.3.6.7203
231. Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, Medrano EE. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res 2002; 62:6231-9; PMID:12414652
232. Shima Y, Shima T, Chiba T, Irimura T, Pandolfi PP, Kitabayashi I. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol 2008; 28:7126-38; PMID:18809579; http://dx.doi.org/ 10.1128/MCB.00897-08
233. Bernassola F, Salomoni P, Oberst A, Di Como CJ, Pagano M, Melino G, Pandolfi PP. Ubiquitin-dependent degradation of p73 is inhibited by PML. J Exp Med 2004; 199:1545-57; PMID:15184504; http://dx.doi.org/10.1084/jem.20031943
234. Xu ZX, Timanova-Atanasova A, Zhao RX, Chang KS. PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol Cell Biol 2003; 23:4247-56; PMID:12773567; http://dx.doi.org/10.1128/MCB.23.12.4247-4256.2003
235. Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 2004; 6:665-72; PMID:15195100; http://dx.doi.org/10.1038/ncb1147
236. Miteva M, Keusekotten K, Hofmann K, Praefcke GJ, Dohmen RJ. Sumoylation as a signal for polyubiquitylation and proteasomal degradation. Subcell Biochem 2010; 54:195-214; PMID:21222284; http://dx.doi.org/10.1007/978-1-4419-6676-6-16
237. Praefcke GJ, Hofmann K, Dohmen RJ. SUMO playing tag with ubiquitin. Trends Biochem Sci 2012; 37:23-31; PMID:22018829; http://dx.doi.org/10.1016/j. tibs.2011.09.002
238. Malloy MT, McIntosh DJ, Walters TS, Flores A, Goodwin JS, Arinze IJ. Trafficking of the transcription factor Nrf2 to promyelocytic leukemia-nuclear bodies: implications for degradation of NRF2 in the nucleus. J Biol Chem 2013; 288:14569-83; PMID:23543742; http://dx.doi.org/10.1074/jbc.M112.437392
239. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011; 475:106-9; PMID:21734707; http://dx.doi.org/10.1038/nature10189
240. Nyström T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 2005; 24:1311-7; PMID:15775985; http://dx.doi.org/10.1038/sj.emboj.7600599
241. Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001; 83:301-10; PMID:11295490; http://dx.doi.org/10.1016/S0300- 9084(01)01250-0
242. Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 2007; 28:730-8; PMID:18082598; http://dx.doi.org/10.1016/j. molcel.2007.11.019
243. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/10.1038/nrc2290
244. Vredeveld LC, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM, Ajouaou A, Kortman PC, Dankort D, McMahon M, et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev 2012; 26:1055-69; PMID:22549727; http://dx.doi.org/ 10.1101/gad.187252.112
245. Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS, McBryan T, Doyle B, McKay C, Oien KA, et al. Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. Mol Cell 2011; 42:36-49; PMID:21474066; http://dx.doi.org/10. 1016/j.molcel.2011.02.020
246. Malleshaiah MK, Shahrezaei V, Swain PS, Michnick SW. The scaffold protein Ste5 directly controls a switch-like mating decision in yeast. Nature 2010; 465:101-5; PMID:20400943; http://dx.doi.org/10.1038/nature08946
247. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6:369-81; PMID:16633365; http://dx.doi.org/10.1038/ nrc1881
248. Lipkowitz S, Weissman AM. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer 2011; 11:629-43; PMID:21863050; http://dx.doi.org/10.1038/nrc3120
249. Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78:399-434; PMID:19489725; http://dx.doi.org/10.1146/annurev. biochem.78.101807.093809
250. Bernassola F, Karin M, Ciechanover A, Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 2008; 14:10-21; PMID:18598940; http://dx.doi.org/10.1016/j.ccr.2008.06.001
251. Hatakeyama S, Nakayama KI. U-box proteins as a new family of ubiquitin ligases. Biochem Biophys Res Commun 2003; 302:635-45; PMID:12646216; http://dx.doi.org/10.1016/S0006-291X(03)00245-6
252. Aravind L, Koonin EV. The U box is a modified RING finger - a common domain in ubiquitination. Curr Biol 2000; 10:R132-4; PMID:10704423; http://dx.doi.org/10.1016/S0960-9822(00)00398-5
253. Coscoy L, Ganem D. PHD domains and E3 ubiquitin ligases: viruses make the connection. Trends Cell Biol 2003; 13:7-12; PMID:12480335; http://dx.doi.org/ 10.1016/S0962-8924(02)00005-3
254. Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, Conaway RC, Conaway JW, Nakayama KI. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 2004; 18:3055-65; PMID:15601820; http://dx.doi.org/10.1101/gad.1252404
255. Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6:9-20; PMID:15688063; http://dx.doi.org/10.1038/nrm1547
256. Ishikawa Y, Hosogane M, Okuyama R, Aoyama S, Onoyama I, Nakayama KI, Nakayama K. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch. Oncogene 2013; 32:1921-32; PMID:22665065; http://dx.doi.org/10.1038/onc.2012.213
257. Roy N, Stoyanova T, Dominguez-Brauer C, Park HJ, Bagchi S, Raychaudhuri P. DDB2, an essential mediator of premature senescence. Mol Cell Biol 2010; 30:2681-92; PMID:20351176; http://dx.doi.org/10.1128/MCB.01480-09
258. Prudden J, Pebernard S, Raffa G, Slavin DA, Perry JJ, Tainer JA, McGowan CH, Boddy MN. SUMO-targeted ubiquitin ligases in genome stability. EMBO J 2007; 26:4089-101; PMID:17762865; http://dx.doi.org/10.1038/sj.emboj.7601838
259. Sun H, Leverson JD, Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J 2007; 26:4102-12; PMID:17762864; http://dx.doi.org/10.1038/sj.emboj.7601839
260. Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, Yang WL, Wang J, Egia A, Nakayama KI, et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 2010; 464:374-9; PMID:20237562; http://dx.doi.org/10.1038/nature08815
261. Muñoz-Espín D, Cañamero M, Maraver A, Gómez-López G, Contreras J, Murillo-Cuesta S, Rodríguez- Baeza A, Varela-Nieto I, Ruberte J, Collado M, et al. Programmed cell senescence during mammalian embryonic development. Cell 2013; 155:1104-18; PMID:24238962; http://dx.doi.org/10.1016/j.cell.2013.10.019
262. Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V, Yosef R, Pilpel N, Krizhanovsky V, Sharpe J, et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013; 155:1119-30; PMID:24238961; http://dx.doi.org/10.1016/j.cell.2013.10. 041
263. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75:685-705; PMID:23140366; http://dx.doi.org/10.1146/annurev-physiol-030212- 183653
264. Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 1999; 17:739-79; PMID:10358773; http://dx.doi.org/10.1146/annurev.immunol.17.1.739
265. Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat Rev Immunol 2008; 8:607-18; PMID:18641646; http://dx.doi.org/10.1038/nri2368
266. Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov 2011; 10:29-46; PMID:21151032; http://dx.doi.org/10.1038/nrd3321
267. Sfeir A, Kabir S, van Overbeek M, Celli GB, de Lange T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 2010; 327:1657-61; PMID:20339076; http://dx.doi.org/10.1126/science. 1185100
268. Martinez P, Thanasoula M, Carlos AR, Gómez-López G, Tejera AM, Schoeftner S, Dominguez O, Pisano DG, Tarsounas M, Blasco MA. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol 2010; 12:768-80; PMID:20622869; http://dx.doi.org/10.1038/ncb2081
269. Hu C, Li H, Li J, Zhu Z, Yin S, Hao X, Yao M, Zheng S, Gu J. Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling. Carcinogenesis 2008; 29:2289-97; PMID:18820285; http://dx.doi.org/10.1093/carcin/bgn223